Oldest cold virus identified in 18th-century woman's lungs

Scientists have identified the oldest confirmed human RNA virus in lung tissue from a woman who died in London around the 1770s. The rhinovirus, which causes the common cold, was reconstructed from fragmented genetic material preserved in alcohol. This discovery opens new possibilities for studying the evolution of RNA viruses in human history.

Genetic analysis has revealed a rhinovirus in lung samples from a woman who lived in London and died about 250 years ago, marking it as the oldest confirmed human RNA virus. Unlike DNA viruses, which can be traced back up to 50,000 years in ancient skeletons, RNA viruses degrade quickly after death, typically within hours. However, researchers have pushed the boundaries of ancient RNA recovery, including from a woolly mammoth that perished 40,000 years ago.

Erin Barnett at the Fred Hutchinson Cancer Center in Seattle led the team in searching European pathology collections for pre-1900s specimens preserved without formalin, which began protecting RNA in the early 20th century. At the Hunterian Anatomy Museum in Glasgow, UK, they examined alcohol-preserved lung tissue from the London woman, who died around the 1770s, and another individual who died in 1877. Both showed signs of severe respiratory illness.

The RNA extracted was highly fragmented, with segments averaging 20 to 30 nucleotides—far shorter than the over 1,000 nucleotides typical in living cells. As Barnett explained, "To put that in perspective, RNA molecules in living cells are usually more than 1000 nucleotides long. So instead of working with long, intact strands, we were piecing together information from many tiny fragments."

The team reconstructed the full rhinovirus genome from the 18th-century sample and detected co-infecting bacteria, including Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. Comparing it to a US National Institutes of Health database of viral genomes, the virus belonged to the human rhinovirus A group, an extinct lineage closest to the modern A19 genotype. Barnett noted, "By comparing it to present-day viruses, we estimate that this historical virus and modern A19 last shared a common ancestor sometime in the 1600s."

Love Dalén at Stockholm University praised the work: "It represents a really important discovery since it demonstrates the possibility of recovering RNA from wet collections that pre-date the use of formalin." He added that it signals "the first phase in what will become an explosion in the study of RNA viruses," given their rapid evolution. Barnett hopes the study honors the individuals: "The stories of these two individuals are largely unknown, and we hope that this study serves to help recognise them."

The findings were detailed in a preprint on bioRxiv (DOI: 10.64898/2026.01.29.702071). Until now, ancient RNA studies focused on rare preserved materials like permafrost or desiccated seeds, limiting insights into past human diseases, Barnett said: "Until now, most ancient RNA studies have relied on exceptionally well-preserved materials, such as permafrost samples or desiccated seeds, which greatly limits what we can learn about past human disease."

Related Articles

Archaeological dig at Bronze Age Arkaim uncovering sheep skeleton with visualized ancient plague DNA against Eurasian steppe landscape.
Image generated by AI

Ancient sheep DNA offers new clues to how a Bronze Age plague spread across Eurasia

Reported by AI Image generated by AI Fact checked

Researchers analyzing ancient DNA say they have detected the plague bacterium Yersinia pestis in the remains of a domesticated sheep from Arkaim, a Bronze Age settlement in the southern Ural region of present-day Russia. The team reports this is the first known identification of a Bronze Age plague lineage in a nonhuman host from that period, a finding that could help explain how an early, pre-flea-adapted form of plague traveled widely across Eurasia.

Scientists have discovered that the body's rapid response in nasal cells largely determines whether a rhinovirus infection leads to a mild cold or more severe symptoms. Using lab-grown human nasal tissue, researchers showed how interferons coordinate defenses to contain the virus early. The findings, published January 19 in Cell Press Blue, emphasize the role of host responses over viral traits alone.

Reported by AI

Scientists have reconstructed the genome of Treponema pallidum from a 5,500-year-old skeleton in Colombia, marking the oldest known instance of this bacterium linked to syphilis and related diseases. The ancient strain diverged early in the pathogen's evolution, suggesting treponemal infections were diversifying in the Americas millennia before European contact. This discovery extends the genetic history of these diseases by over 3,000 years.

Researchers at the University of California, San Francisco have identified how aging lungs contribute to severe flu and COVID-19 outcomes in older adults. Their study shows that lung fibroblasts trigger excessive inflammation, forming damaging clusters of immune cells. The findings, published in Immunity on March 27, suggest potential new treatments.

Reported by AI

Researchers led by Gianni Barcaccia at the University of Padova have identified DNA from numerous animals, plants, and humans contaminating the Shroud of Turin. The new study reexamines material collected in 1978, revealing traces that suggest extensive handling and possible links to India. Findings complicate debates over the relic's medieval origins.

A repurposed breast cancer drug called MDL-001 has shown promise in lab and animal studies against a range of viruses, including flu, covid-19, RSV and norovirus. Developed by California-based Model Medicines using AI, the pill targets a conserved enzyme domain in viruses. A clinical trial is planned for early next year.

Reported by AI Fact checked

Researchers analyzing immune cells from people with long COVID have identified a distinct molecular state in CD14+ monocytes—labeled “LC-Mo”—that was more prevalent among patients whose initial COVID-19 illness was mild to moderate and that tracked with reported fatigue and respiratory symptoms, along with higher levels of inflammatory signaling molecules in blood plasma.

This website uses cookies

We use cookies for analytics to improve our site. Read our privacy policy for more information.
Decline